An engineered factor Va prevents bleeding induced by anticoagulant wt activated protein C
about
Safety, Stability and Pharmacokinetic Properties of (super)Factor Va, a Novel Engineered Coagulation Factor V for Treatment of Severe Bleeding.New and Emerging Agents for the Treatment of Hemophilia: Focus on Extended Half-Life Recombinant Clotting Proteins.Improved coagulation and haemostasis in haemophilia with inhibitors by combinations of superFactor Va and Factor VIIa.
P2860
An engineered factor Va prevents bleeding induced by anticoagulant wt activated protein C
description
2014 nî lūn-bûn
@nan
2014 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
An engineered factor Va prevents bleeding induced by anticoagulant wt activated protein C
@ast
An engineered factor Va prevents bleeding induced by anticoagulant wt activated protein C
@en
An engineered factor Va prevents bleeding induced by anticoagulant wt activated protein C
@nl
type
label
An engineered factor Va prevents bleeding induced by anticoagulant wt activated protein C
@ast
An engineered factor Va prevents bleeding induced by anticoagulant wt activated protein C
@en
An engineered factor Va prevents bleeding induced by anticoagulant wt activated protein C
@nl
prefLabel
An engineered factor Va prevents bleeding induced by anticoagulant wt activated protein C
@ast
An engineered factor Va prevents bleeding induced by anticoagulant wt activated protein C
@en
An engineered factor Va prevents bleeding induced by anticoagulant wt activated protein C
@nl
P2093
P2860
P1433
P1476
An engineered factor Va prevents bleeding induced by anticoagulant wt activated protein C
@en
P2093
Andrew J Gale
Annette von Drygalski
Laurent O Mosnier
Thomas J Cramer
Vikas Bhat
P2860
P304
P356
10.1371/JOURNAL.PONE.0104304
P407
P577
2014-08-15T00:00:00Z